USD 2.2 billion
Molecular Cytogenetics Market Size, Share, Growth Analysis, By Product(Consumables, instruments, kits and reagents, software and services and others), By End user(Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical, and Biotechnology Companies), By Application(Cancer, genetics), By Technique(In-Situ, FISH, Comparative Genomic Hybridization), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2165 |
Region:
Global |
Published Date: February, 2024
Pages:
242
|Tables:
118
|Figures:
78
Molecular Cytogenetics Market Insights
Molecular Cytogenetics Market size was valued at USD 2.2 billion in 2019 and is poised to grow from USD 2.39 billion in 2023 to USD 4.66 billion by 2031, growing at a CAGR of 8.7% in the forecast period (2024-2031).
In order to discriminate between healthy cells and cancer-causing cells, molecular cytogenetics merges the fields of molecular biology and cytogenetics. When it was revealed that typical human cells have 46 chromosomes, human cytogenetics got its start. The study of molecular cytogenetics can be helpful in identifying and treating a variety of malignancies, including brain tumours, haematological malignancies, and other cancer-related precursors. The field's overall focus is on chromosomal evolution, specifically the prevalence, makeup, purpose, and origin of chromosome abnormalities. It consists of a set of procedures known as fluorescence in situ hybridization, or FISH, in which DNA probes are marked with various fluorescent tags in order to see one or more particular areas of the genome.
One of the main drivers propelling the market's expansion is the rising incidence of cancer and other genetic illnesses, as well as the growing geriatric population. The main applications of molecular cytogenetics are the development of future models of disease features and efficient therapeutic approaches. The market expansion is also being aided by the increased use of targeted therapies for the treatment of cancer. To identify cancer stages and give each patient a customised course of treatment, pharmacogenomic biomarker studies also use FISH and Comparative Genomic Hybridization.
Other growth-promoting elements include various technological developments, such as the creation of enhanced consumables, reagents, software, and kits. These developments help produce reproducible, precise, and trustworthy clinical-pathological test outcomes. The market is expected to be further fueled by additional factors, such as notable advancements in healthcare infrastructure and large investments in biomedical research and development.
US Molecular Cytogenetics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
kits and reagents
Fastest Growth
kits and reagents
Growth Rate
8.7% CAGR
Global Molecular Cytogenetics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Molecular Cytogenetics Market Segmental Analysis
Global Molecular Cytogenetics Market is segmented on the basis of product type, end user, application, technique, and region. By Product, the market is sub-segmented consumables, instruments, kits and reagents, software and services. By application, the market is segmented into Cancer, genetics. Based on technique, the market is segmented into In-Situ, FISH, Comparative Genomic Hybridization . By End user, the market is categorized into Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical, and Biotechnology Companies. By region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and MEA.
Molecular Cytogenetics Market Analysis by Product Type
By product type, the global molecular cytogenetics market is segmented into consumables, instruments, kits and reagents, software and services. Global Molecular Cytogenetics Market for the Kits & Reagents segment is anticipated to be the largest as well as fastest growing over the estimated period. The use of kits allows remarkable time saving and reduction of manual procedures bringing benefits to the routine laboratory. Increasing focus toward targeted cancer treatment and rising demand in emerging markets are driving the growth of the segment.
Molecular Cytogenetics Market Analysis by End User
By End user, the market is segmented into Clinical & Research Laboratories, Academic Research Institutes, Pharmaceutical, and Biotechnology Companies, and Other End-User. The Global Molecular Cytogenetics Market for Clinical & Research Laboratories segment is anticipated to be largest during the forecast period. Molecular cytogenetic techniques enable the detection of complicated, cryptic, and submicroscopic rearrangements.
Global Molecular Cytogenetics Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
Molecular Cytogenetics Market Regional Insights
North America is anticipated to amass a 31.2% revenue share globally in 2022. North America dominates the worldwide molecular cytogenetics market in terms of revenue thanks to the region's abundance of academic and research institutions as well as clinical research facilities. The molecular cytogenetics market is additionally boosted by an increase in cancer incidences, rising government and private healthcare spending, and improved healthcare infrastructure in this area.
Due to its big population in need, high birth rate, expanding caseload of pre and postnatal problems, and rising number of cases of various types of cancer, Europe is predicted to see the largest market growth. The region's expanding research and development activities, increased government involvement, rising public knowledge of cancer molecular biomarkers, and improved healthcare infrastructure are all factors contributing to the market's expansion.
Asia is predicted to experience rapid expansion in the molecular cytogenetics industry over the next five years. The rising need for genetic tests, improvements in healthcare infrastructure, and a sizable patient pool in nations like India and China are some of the factors boosting the expansion of molecular cytogenetics in emerging economies.
Global Molecular Cytogenetics Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Molecular Cytogenetics Market Dynamics
Molecular Cytogenetics Market Drivers
Increasing Cancer Cases to Boost Market Growth
- Molecular cytogenetics combines cytogenetics and molecular biology. Over the course of the projected period, rising molecular cytogenetics use is anticipated to drive market expansion. The usage of molecular cytogenetics is also anticipated to increase with the occurrence of cancer.
Molecular Cytogenetics Market Restraints
Strict Regulations to Hinder Market Growth
- Unfavourable reimbursement policies represent a major restraint for the market. Insurance companies are refraining from reimbursing molecular diagnostic tests. High cost of genetic testing is also expected to limit the market growth. The cost of these tests typically range from USD 300 per test and are considered the most important technologies for early detection.
Request Free Customization of this report to help us to meet your business objectives.
Molecular Cytogenetics Market Competitive Landscape
With numerous small and major market players present and active globally, the global market for molecular cytogenetics is highly fragmented.Major market players are using a variety of business methods, including new product releases, acquisitions and mergers, collaboration, and partnerships, to broaden their geographic reach and product offering.
Molecular Cytogenetics Market Top Players Company Profiles
- Agilent Technologies, Inc.
- Applied Spectral Imaging (ASI) Ltd.
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- Leica Biosystems Nussloch GmbH
- Luminex Corporation
- Oxford Gene Technology IP Limited
- PerkinElmer Inc.
- Promega Corporation
- QIAGEN N.V.
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Biochain Institute Inc.
- Cytocell Ltd.
- Empire Genomics, LLC
- MetaSystems GmbH
- Natera, Inc.
- Sigma-Aldrich Corporation
Molecular Cytogenetics Market Recent Developments
- In August 2022 -Agilent Technologies Inc. declared that it has purchased Polymer Standards Service GmbH (PSS), a company that offers services for characterization of polymers. PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solutions for gel permeation chromatography (GPC) and size exclusion chromatography (SEC) used in applications to determine the molecular weight and size distribution of macromolecules.
Molecular Cytogenetics Key Market Trends
- A good understanding of genomes is essential for attaining numerous goals in cancer care, including therapeutic options, rapid and exact diagnosis, survival prediction, and estimating recurrence risk. Oncology has emerged as the largest application category due to the effectiveness and widespread use of molecular cytogenetic techniques for in-depth cancer studies. The two most essential ways for generating better treatment outcomes are pharmacotherapies and individualized therapy alternatives. The usage of molecular cytogenetic techniques is predicted to expand lucratively over the forecast period, owing to a shift toward individualized therapy.
Molecular Cytogenetics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our global molecular cytogenetics market analysis, Tapping in emerging economies is expected to offer lucrative growth opportunities for players in the global molecular cytogenetics market. FISH and array based technologies have high penetration rate in developed economies such as the U.S and Europe owing to high level of public awareness and adoption rate. Merging Asian and Latin American economies have low adoption rates owing to low patient awareness levels. Economic developments in these regions coupled with rising disposable income of patients and increasing awareness are shifting the attention of medical practitioners towards molecular tests. Rising incidence of cancer and genetic disorders in emerging economies is also expected to boost demand for molecular cytogenetic technologies in these regions.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 2.2 billion |
| Market size value in 2031 | USD 4.66 billion |
| Growth Rate | 8.7% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
Molecular Cytogenetics Market Recent Developments
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
| Historical Year | 2019 |
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Molecular Cytogenetics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Molecular Cytogenetics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Molecular Cytogenetics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Molecular Cytogenetics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Molecular Cytogenetics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Molecular Cytogenetics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
